, opens new tab recorded a $5.8 billion impairment charge on its investment in clinic operator VillageMD on Thursday, hit by a cost-cutting drive to shut down unprofitable sites. VillageMD, a core ...
Walgreens confirmed Tuesday a new round of layoffs, the latest in a string of job cuts over the past year as the retail ...
March 28 (Reuters) - Walgreen Boots Alliance WBA.Ocut the higher end of its profit forecast for fiscal-year 2024 on Thursday, citing economic challenges for its retail operations, and took a $5.8 ...
Walgreens reported an almost $6 billion net loss in the second quarter, according to financial results released Thursday. Nearly all of that sum was attributable to the declining value of a ...
No-moat Walgreens Boots Alliance reported fiscal second-quarter results that came in higher than our expectations. Total sales of $37.1 billion and adjusted earnings per share of $1.20 were up 6.3 ...
But Walgreens' new CEO, Tim Wentworth, thinks the company has an advantage, particularly over a company such as Amazon, which ...
Walgreens's retail sales hit by a challenging retail environment, channel shift, and a weaker respiratory season. Walgreens Boots Alliance narrowed the fiscal year 2024 adjusted EPS guidance to $3 ...
Walgreens Boots Alliance announced that it is taking a $5.8 billion loss on its VillageMD clinics, which the company purchased a major stake in three years ago. The company announced in its Q2 ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.
Retail pharmacy giant Walgreens Boots Alliance Inc (NASDAQ:WBA) is bolstering its specialty pharmacy services, aiming to ...
Walgreens reported a steep quarterly loss, reflecting a nearly $6 billion write-down in the value of its investment in primary care clinic chain VillageMD. The drugstore chain invested $1 ...
Walgreens Boots Alliance Inc’s (NASDAQ: WBA) second quarter fiscal year 2024 sales increased 6.3% Y/Y to $37.1 billion, up 5.7% on a constant currency basis, beating the consensus of $35.86 billion.